Worldwide funding programs
JPI-HDHL
The HDHL-INTIMIC partners pre-announce the launch of a 2nd joint funding activity “Knowledge Platform on Food, Diet, Intestinal Microbiomics and Human Health” expected on September 4th 2018.
- aims to establish a Knowledge Platform on Food, Diet, Intestinal Microbiomics and Human Health
- connect all funded JPI HDHL researchers with other existing initiatives and relevant stakeholders in the human microbiome and health research area.
- carry out joint multidisciplinary activities aiming at integrating expertise, knowledge, facilities and databases in areas such as biology, medicine, nutrition and (bio) informatics
- activities of the platform should focus on the current research challenges in the field, for example: Standardisation and harmonization, Data handling, knowledge and data sharing, Move from association to causality
- Time line: Expression of Interest (EoI) to join the platform until October 9th 2018.
EU COST Action - European Cooperation in Science and Technology
COST Actions do not finance research itself, but pan-European networking to an innovative research topic. Project applications can be submitted at any time. Next collection date: 29th November 2018 at 12:00 noon (CET). The minimum number of countries included in the network has increased to seven Full or Cooperating COST Members. Out of the seven, a minimum of 50% must be Inclusiveness Target Countries .
EU Innovative Medicines Initiative
15. IMI2-Aufruf (zweistufig):
- Integrated Research Platforms enabling Patient-Centric Drug Development
- Blockchain Enabled Healthcare
- Microenvironment imposed signatures in tissue and liquid biopsies in immune mediated disease
- Emerging translational safety technologies and tools for interrogating human immuno-biology
- Development and validation of translational platforms in support of synaptopathy drug discovery
- Digital Transformation of Clinical Trials Endpoints
- Pillar A (AMR Accelerator programme): Capability Building Network to accelerate and validate scientific discoveries
- Pillar B (AMR Accelerator programme): Tuberculosis drug development network to accelerate and validate scientific discoveries and advance the R&D pipeline of new and innovative agents to address the global tuberculosis epidemic
16. IMI2-Aufruf (einstufig):
- Pillar C (AMR Accelerator Programme ): Portfolio Building Networks to advance the R&D pipeline of new and innovative agents to address AMR
EU Horizon 2020
1. Better Health and care, economic growth and sustainable health systems (BHC)
H2020-SC1-BHC-2019 - two stages
You may include partners from the USA
Deadlines: 02.10.2018 (Sketch), 16.04.2019 (full proposal)
- SC1-BHC-01-2019: Understanding causative mechanisms in co- and multimorbidities (RIA)
- SC1-BHC-02-2019: Systems approaches for the discovery of combinatorial therapies for complex disorders (RIA)
- SC1-BHC-14-2019: Stratified host-directed approaches to improve prevention, treatment and/or cure of infectious diseases (RIA)
- SC1-BHC-19-2019: Implementation research for maternal and child health (RIA)
- SC1-BHC-22-2019: Mental health in the workplace (RIA)
- SC1-BHC-25-2019: Demonstration pilots for implementation of personalised medicine in healthcare (IA)
H2020-SC1-BHC-2019 - single stage
You may include partners from the USA
Deadline: 16.04.2019 (full proposal)
- SC1-BHC-07-2019: Regenerative medicine: from new insights to new applications (RIA)
- SC1-BHC-13-2019: Mining big data for early detection of infectious disease threats driven by climate change and other factors (RIA)
- SC1-BHC-28-2019: The Human Exposome Project: a toolbox for assessing and addressing the impact of environment on health (RIA)
- SC1-BHC-10-2019: Innovation Procurement: Next generation sequencing (NGS) for routine diagnosis (PCP)
- SC1-HCO-01-2018-2019-2020: Actions in support of the International Consortium for Personalised Medicine (CSA)
2. Digital transformation in Health and Care (DTH)
H2020-SC1-DTH-2019 - single stage
You may include partners from the USA
Deadline: 14.11.2018 (full proposal)
Deadline: 24.04.2019 (full proposal)
- SC1-DTH-01-2019: Big data and Artificial Intelligence for monitoring health status and quality of life after the cancer treatmenth (RIA)
- SC1-DTH-05-2019: Large scale implementation of digital innovation for health and care in an ageing society (PPI)
- SC1-DTH-09-2019: Scaling up the univocal Identification of Medicinal Products (IA)
- SC1-DTH-11-2019: Large Scale pilots of personalised & outcome based integrated care (IA)
- SC1-HCC-02-2019: Support for the large scale uptake of open service platforms in the Active and Healthy Ageing domain (CSA)
3. Trusted digital solutions and Cybersecurity in Health and Care (FA-DTS)
H2020-SC1-FA-DTS-2019 - single stage
Deadline: 14.11.2018 (full proposal)
4. Sustainable Food Security
From funtional ecosystems to healthy food
Deadlines: 23.01.2019 (sketch), 04.09.2019 (full proposal)
5. Socioeconomic and Cultural Transformations in the Context of the Fourth Industrial Revolution
Deadline: 14.03.2019 (full proposal)
USA | |
| DE, US | The pre-application should be submitted the the first stage and they should clearly incorporate and differentiate the US-american research contributions. Information for single calls on the CIRM-web site. application model: two-stage |
NIH funding news that may be relevant to global health researchers
- Notice of Change to Eligible Organizations in NIAID PAR-18-335 Global Infectious Disease Research Administration Development Award for Low-and Middle-Income Country Institutions (G11 Clinical Trial Not Allowed) (NOT-AI-18-041)
Note: Beginning with the July 31, 2018 application due date, the Eligible Organizations must have received no more than $8 million in total NIH grant and/or cooperative agreement direct award support in the last 5 years at the time of application submission. - Clarification: Assignment Deadlines for Applications Submitted Under the NIH Continuous Submission Policy (NOT-OD-18-178)
